NCT04447235: Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection
- State
- Stopped early
- Phase
- Phase 2
- People
- 77 taking part
- Started
- 23 Jul 2020
- Primary completion
- 30 Jun 2022
- Arms
- ARM B: Ivermectin plus losartan
- Results
- None posted
- 25 Jun 2020: Trial registered
- 23 Jul 2020: Trial started
- 30 Jun 2022: Trial terminated